DUBLIN, Nov. 5, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rhp4x5/global_insomnia) has announced the addition of the "Global Insomnia Market - Market Research Analysis 2015-2019" report to their offering.
The global insomnia market to decline at a CAGR of 3.08% over the period 2014-2019.
The report includes the present scenario and the growth prospects of the global insomnia market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of insomnia.
The report includes a discussion of the key vendors operating in this market.
Vendors are entering into strategic alliances with other vendors and universities for the research, development, manufacture, and distribution of drugs. The trend is predicted to continue during the forecast period.
According to the report, People's growing awareness of the importance of sleep will motivate individuals with insomnia to seek treatment. The low diagnosis rate for insomnia is due to the lack of awareness and identification of symptoms. Therefore, awareness campaigns and initiatives by hospitals and healthcare centers will help people understand the consequences of sleep disturbances and motivate them to seek treatment, thus driving the global insomnia drugs market.
Further, the report states that the branded drugs indicated for insomnia are expected to lose their patents during the forecast period. Patent expiry is poised to impact the market significantly by slowing down the market's growth rate.
Other prominent vendors
- Dainippon Sumitomo
- ECR Pharmaceuticals (Valeant)
- Fidia Farmaceutici
- Flynn Pharma
- Johnson & Johnson
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Insomnia: An overview
Part 06: Market landscape
Part 07: Pipeline portfolio
Part 08: Market segmentation by type of formulation
Part 09: Market segmentation by symptom
Part 10: Geographical segmentation
Part 11: Market drivers
Part 12: Impact of drivers
Part 13: Market challenges
Part 14: Impact of drivers and challenges
Part 15: Market trends
Part 16: Vendor landscape
Part 17: Key vendor analysis
Part 18: Appendix
For more information visit
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets